GLPwatch
Trials (2167)
Page 33 of 37.
- The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes
- A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus
- Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
- Liraglutide Effects on Epicardial Fat Inflammatory Genes
- Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects
- Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions
- Semaglutide Use in Acute Pulmonary Embolism
- Preoperative Condition in Giant Obese Patients
- Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy
- Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
- A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes
- Liver and Fat Regulation in Overweight Adolescent Girls
- iGlarLixi CGM Study in Chinese T2D Individuals After OADs
- Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
- A Study of IBI362 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise
- Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients
- A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years
- A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)
- Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin
- Effects of GLP-1 RAs on Human Lactation Outcomes
- Daily Liraglutide for Nicotine Dependence
- A Study of Cardiovascular Events iN Diabetes Plus
- Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus
- DIALYSIS-TIR Study
- A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
- Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan
- Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DM
- The Gut Microbiome in Women With Polycystic Ovary Syndrome
- A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes
- Autoinjector Device Assessment Study
- Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD
- A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight
- A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification
- Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes
- Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)
- Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE)
- Latino Semaglutide Study
- Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects
- Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes
- A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin
- Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.
- Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes Mellitus
- Combined Active Treatment in Type 2 Diabetes With NASH
- Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes
- A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus
- A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
- Separate and Combined Extrapancreatic Effects of GIP and GLP-1
- Study to Evaluate the Effect of Lixisenatide in Patient With Parkinson's Disease
- Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss
- Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid
- Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin
- Metabolic Defects in Prediabetic Kuwaiti Arabs and Indians
- Safety, Tolerability and Pharmacokinetics of a Subcutaneous Semaglutide Implant
- FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes
- Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
- Ultrasound Assessment of the Carotid Intimal Medial Thickness in Obese Subjects; Weight Loss
- Effects of GH and Lirglutide on AgRP
- Semaglutide 2.4mg for Low Responders After Bariatric Surgery
- Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation